The Efficacy and Safety of Trilaciclib in Bone Marrow Protection Before Chemotherapy for Advanced Bile Duct Cancer and Pancreatic Cancer
Clinical trial NCT07160283 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07160283
- Sponsor
- The Second Affiliated Hospital of Shandong First Medical University
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-09-01
- Primary completion
- 2027-09-01
- Enrollment
- 96
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.